{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:35:38Z","timestamp":1785544538868,"version":"3.56.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Social Development Project of Fuzhou, Fujian, P.R.C","award":["Grant number 2024-S-093"],"award-info":[{"award-number":["Grant number 2024-S-093"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Charcot foot (CF) is a severe, progressive neuro-osteoarthropathy predominantly affecting diabetic patients with peripheral neuropathy. Characterized by progressive bone and joint destruction, CF can lead to debilitating foot deformities, ulceration, infection, and ultimately lower extremity amputation. Despite its significant clinical impact, the global prevalence remains uncertain, with an estimated 1.6 million people affected worldwide. Early diagnosis is challenging due to the insidious onset and limited specificity of current clinical, imaging, and laboratory assessments. The role of circulating metabolites in CF pathogenesis remains poorly understood. This study aimed to investigate the causal relationship between plasma metabolites and CF risk using Mendelian randomization (MR) and to identify potential biomarkers for early detection and therapeutic intervention. We conducted a bidirectional 2-sample MR study using genome-wide association study summary data. Plasma metabolite data were obtained from a cohort of approximately 8000 individuals of European descent (genome-wide association study catalog: GCST90199621\u2013GCST90201020), and CF summary statistics were derived from the FinnGen Study (9th version), comprising 473 cases and 271,817 controls. Genetic instrumental variables were selected through linkage disequilibrium clumping and harmonization. The inverse-variance weighted method served as the primary analysis, supplemented by MR-Egger, weighted median, and weighted mode methods. Sensitivity analyses included Cochran\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      test, Egger intercept test, MR-Pleiotropy RESidual Sum and Outlier, and leave-one-out analyses. Multivariable MR and colocalization analyses were performed to validate the findings. After false discovery rate adjustment, octadecadienedioate demonstrated a significant negative association with CF risk (odds ratio\u2005=\u20050.644, 95% confidence interval 0.528\u20130.785, false discovery rate\u2005=\u20050.018). This protective association was consistent across all MR methods, robust in sensitivity analyses, and further supported by multivariable MR (odds ratio\u2005=\u20050.632, 95% confidence interval 0.479\u20130.834) and colocalization analysis (posterior probability 4\u2005=\u20050.945). Reverse MR analysis revealed no significant causal effects from CF to metabolite levels. Our findings identify octadecadienedioate as a novel protective factor against CF, highlighting the potential of circulating metabolites in understanding CF pathogenesis. These results may inform future preventive strategies, biomarker development, and personalized diabetic foot care.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049973","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:23Z","timestamp":1785533303000},"page":"e49973","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Plasma metabolite octadecadienedioate: A novel protective factor against diabetes-related Charcot foot"],"prefix":"10.1097","volume":"105","author":[{"given":"Daosen","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of General Surgery, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diya","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-2750","authenticated-orcid":false,"given":"Fengmin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Fuzhou First General Hospital Affiliated with Fujian Medical University, Fuzhou, Fujian, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260731","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12875-024-02387-4","article-title":"Developing an interprofessional decision support tool for diabetic foot ulcers management in primary care within the family medicine group model: a Delphi study in Canada.","volume":"25","author":"Brousseau-Foley","year":"2024","journal-title":"BMC Prim Care"},{"key":"R2-20260731","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00125-022-05845-9","article-title":"Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century.","volume":"66","author":"Lazzarini","year":"2023","journal-title":"Diabetologia"},{"key":"R3-20260731","doi-asserted-by":"crossref","first-page":"e3654","DOI":"10.1002\/dmrr.3654","article-title":"Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update).","volume":"40","author":"van Netten","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"R4-20260731","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/15347346211025893","article-title":"Incidence and predictive factors for amputations derived from Charcot\u2019s neuroarthropathy in persons with diabetes.","volume":"22","author":"Bandeira","year":"2023","journal-title":"Int J Low Extrem Wounds"},{"key":"R5-20260731","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/diacare.26.5.1435","article-title":"Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort.","volume":"26","author":"Lavery","year":"2003","journal-title":"Diabetes Care"},{"key":"R6-20260731","doi-asserted-by":"crossref","first-page":"e130423215752","DOI":"10.2174\/1573399819666230413094200","article-title":"Prevalence of diabetes in India: a review of IDF diabetes atlas 10th edition.","volume":"20","author":"Kumar","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"R7-20260731","first-page":"100239","article-title":"An overview of Charcot\u2019s neuroarthropathy.","volume":"22","author":"Dardari","year":"2020","journal-title":"J Clin Transl Endocrinol"},{"key":"R8-20260731","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/15347346241252549","article-title":"Genetic signature for the causation of Charcot neuro-osteoarthropathy of foot in diabetes: a systematic review.","volume":"24","author":"Sharma","year":"2025","journal-title":"Int J Low Extrem Wounds"},{"key":"R9-20260731","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/10711007251316556","article-title":"Incidence and factors associated with nonunion following naviculocuneiform joint arthrodesis.","volume":"46","author":"Kim","year":"2025","journal-title":"Foot Ankle Int"},{"key":"R10-20260731","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1007\/s00125-024-06271-9","article-title":"Risk factors for Charcot foot development in individuals with diabetes mellitus.","volume":"67","author":"Tsatsaris","year":"2024","journal-title":"Diabetologia"},{"key":"R11-20260731","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3390\/jcm9061779","article-title":"Diabetic foot infections: the diagnostic challenges.","volume":"9","author":"Lauri","year":"2020","journal-title":"J Clin Med"},{"key":"R12-20260731","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3949\/ccjm.77a.09163","article-title":"Charcot neuroarthropathy: an often overlooked complication of diabetes.","volume":"77","author":"Botek","year":"2010","journal-title":"Cleve Clin J Med"},{"key":"R13-20260731","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.3390\/jcm9061645","article-title":"Comparison of white blood cell scintigraphy, FDG PET\/CT and MRI in suspected diabetic foot infection: results of a large retrospective multicenter study.","volume":"9","author":"Lauri","year":"2020","journal-title":"J Clin Med"},{"key":"R14-20260731","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/15347346241253451","article-title":"Charcot foot: an update on diagnosis, treatment, and areas of uncertainty.","volume":"24","author":"Rebelos","year":"2025","journal-title":"Int J Low Extrem Wounds"},{"key":"R15-20260731","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12916-024-03272-8","article-title":"Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.","volume":"22","author":"Chen","year":"2024","journal-title":"BMC Med"},{"key":"R16-20260731","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for investigating physiological and pathophysiological processes.","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol Rev"},{"key":"R17-20260731","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nutres.2023.08.009","article-title":"Lower serum branched-chain amino acid catabolic intermediates are predictive signatures specific to patients with diabetic foot.","volume":"119","author":"Wang","year":"2023","journal-title":"Nutr Res"},{"key":"R18-20260731","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R19-20260731","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/jcsm.13479","article-title":"Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for sarcopenia.","volume":"15","author":"Yin","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R20-20260731","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00125-024-06149-w","article-title":"Non-adherence to cardiometabolic medication as assessed by LC-MS\/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus.","volume":"67","author":"Denicol\u00f2","year":"2024","journal-title":"Diabetologia"},{"key":"R21-20260731","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R22-20260731","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1038\/s41586-023-05837-8","article-title":"Author Correction: FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"615","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R23-20260731","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fgene.2020.00157","article-title":"LDlinkR: an R package for rapidly calculating linkage disequilibrium statistics in diverse populations.","volume":"11","author":"Myers","year":"2020","journal-title":"Front Genet"},{"key":"R24-20260731","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"R25-20260731","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R26-20260731","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R27-20260731","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12916-023-02881-z","article-title":"The effects of coagulation factors on the risk of endometriosis: a Mendelian randomization study.","volume":"21","author":"Li","year":"2023","journal-title":"BMC Med"},{"key":"R28-20260731","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","article-title":"Calculating statistical power in Mendelian randomization studies.","volume":"42","author":"Brion","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R29-20260731","doi-asserted-by":"crossref","first-page":"e003523","DOI":"10.1136\/bmjdrc-2023-003523","article-title":"Unraveling shared risk factors for diabetic foot ulcer: a comprehensive Mendelian randomization analysis.","volume":"11","author":"Yin","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R30-20260731","doi-asserted-by":"crossref","first-page":"5434","DOI":"10.1002\/sim.9133","article-title":"Testing and correcting for weak and pleiotropic instruments in two-sample multivariable Mendelian randomization.","volume":"40","author":"Sanderson","year":"2021","journal-title":"Stat Med"},{"key":"R31-20260731","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"key":"R32-20260731","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2337\/dc21-0369","article-title":"Fractures and osteoporosis in patients with diabetes with Charcot foot.","volume":"44","author":"Rabe","year":"2021","journal-title":"Diabetes Care"},{"key":"R33-20260731","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1302\/0301-620X.104B6.BJJ-2022-0127","article-title":"Predictors of metalwork failure and nonunion after hindfoot Charcot reconstruction.","volume":"104-B","author":"Najefi","year":"2022","journal-title":"Bone Joint J"},{"key":"R34-20260731","first-page":"1944","article-title":"Novel biomarkers predictive of diabetic Charcot foot-an overview of the literature.","volume":"12","author":"Bobirc\u0103","year":"2022","journal-title":"Life (Basel)"},{"key":"R35-20260731","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13023-015-0290-1","article-title":"Clinical and biochemical characterization of four patients with mutations in ECHS1.","volume":"10","author":"Ferdinandusse","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R36-20260731","doi-asserted-by":"crossref","first-page":"783780","DOI":"10.3389\/fimmu.2021.783780","article-title":"Parsing the role of PPARs in macrophage processes.","volume":"12","author":"Toobian","year":"2021","journal-title":"Front Immunol"},{"key":"R37-20260731","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.clnu.2012.03.002","article-title":"Conjugated linoleic acid modulates immune responses in patients with mild to moderately active Crohn\u2019s disease.","volume":"31","author":"Bassaganya-Riera","year":"2012","journal-title":"Clin Nutr"},{"key":"R38-20260731","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders.","volume":"78","author":"Houten","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"R39-20260731","doi-asserted-by":"crossref","first-page":"1430675","DOI":"10.3389\/fendo.2024.1430675","article-title":"Genetic associations between gut microbiota and type 2 diabetes mediated by plasma metabolites: a Mendelian randomization study.","volume":"15","author":"Zheng","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R40-20260731","doi-asserted-by":"crossref","first-page":"e174186","DOI":"10.1172\/JCI174186","article-title":"Dietary dicarboxylic acids provide a nonstorable alternative fat source that protects mice against obesity.","volume":"134","author":"Goetzman","year":"2024","journal-title":"J Clin Invest"},{"key":"R41-20260731","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/ije\/dyx034","article-title":"MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data.","volume":"46","author":"Yavorska","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R42-20260731","doi-asserted-by":"crossref","first-page":"bbad407","DOI":"10.1093\/bib\/bbad407","article-title":"Benchmarking of local genetic correlation estimation methods using summary statistics from genome-wide association studies.","volume":"24","author":"Zhang","year":"2023","journal-title":"Brief Bioinform"},{"key":"R43-20260731","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fimmu.2014.00354","article-title":"Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications.","volume":"5","author":"Szondy","year":"2014","journal-title":"Front Immunol"},{"key":"R44-20260731","first-page":"e50988","article-title":"A review on relationship between Charcot neuroarthropathy and diabetic patients.","volume":"15","author":"Bansod","year":"2023","journal-title":"Cureus"},{"key":"R45-20260731","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/jssc.201901013","article-title":"Metabolomics study of different parts of licorice from different geographical origins and their anti-inflammatory activities.","volume":"43","author":"Bai","year":"2020","journal-title":"J Sep Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:28:28Z","timestamp":1785533308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":45,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049973","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2024-10-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}